STOCK TITAN

AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
AbCellera (Nasdaq: ABCL) executives will present at the Jefferies London Healthcare Conference on November 14, 2023. A live webcast will be available on AbCellera's Investor Relations website.
Positive
  • None.
Negative
  • None.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Jefferies London Healthcare Conference on Tuesday, November 14, 2023, at 4:30 p.m. Greenwich Mean Time (8:30 a.m. Pacific Time).

A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.
AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. AbCellera’s engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to clinic in nearly every therapeutic area with precision and speed. AbCellera provides innovative biotechs and leading pharmaceutical companies with a competitive advantage that empowers them to move quickly, reduce cost, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.

Inquiries

Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774

Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005

Investor Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.

FAQ

When will AbCellera executives present at the Jefferies London Healthcare Conference?

AbCellera executives will present on Tuesday, November 14, 2023.

Where can I access the live webcast of the presentation?

The live webcast can be accessed through a link on AbCellera's Investor Relations website.

Will there be a replay of the presentation?

Yes, a replay will be available through the same link following the presentation.

AbCellera Biologics Inc. Common Shares

NASDAQ:ABCL

ABCL Rankings

ABCL Latest News

ABCL Stock Data

827.03M
208.65M
27.93%
39.78%
5.39%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
VANCOUVER